Target intelligence / Profile preview

Mucin and epithelial cell surface protein (May be abbreviated as "MUC" for specific family members (e.g., MUC1, MUC4, MUC16), but there is no standardized abbreviation for the broad group "mucins and epithelial cell surface proteins")

Target
May be abbreviated as "MUC" for specific family members (e.g., MUC1, MUC4, MUC16), but there is no standardized abbreviation for the broad group "mucins and epithelial cell surface proteins"
Molecular classification
Glycoprotein, Transmembrane protein (for cell surface mucins), Secreted protein (for gel-forming mucins), Receptor-like properties (signaling domains), Other (e.g., decoy barrier, adhesion molecule)
01

Overview

Mucins are a diverse family of large, heavily glycosylated proteins expressed by epithelial tissues throughout the body. Cell surface mucins (such as MUC1, MUC4, MUC16) are transmembrane glycoproteins that coat the apical surface of epithelial cells, forming a protective barrier against pathogens and environmental insults. They modulate inflammation, regulate cell signaling pathways, and maintain epithelial integrity. Gel-forming mucins are secreted and constitute a major component of mucus. Dysregulation and overexpression of mucins, especially altered glycosylation patterns, are implicated in cancer, chronic inflammation, and susceptibility to infection. Cell surface mucins are important therapeutic targets and clinical biomarkers, though challenges remain due to their biochemical complexity and physiological importance.

Other names
Mucins (family: MUC1, MUC2, MUC4, MUC5AC, MUC6, MUC16, etc.)Cell surface mucinsTethered mucinsEpithelial mucinsAlternative names depend on the specific mucin; the generic term lacks precise aliases
02

Mechanism of action

Antibody-mediated targeting (direct cytotoxicity, immune cell recruitment). Inhibition of mucin-mediated cell signaling. Disruption of surface barrier to sensitize cells to therapy (e.g., improved drug delivery by altering mucin layer).

03

Biological functions

Barrier protection (block pathogens, chemical injury)Modulation of immune responses and inflammationCell signaling and transcription regulationCell adhesion and separationLubrication of epithelial surfacesControl of mineralization (some mucins)Interaction with extracellular matrix and cell-cell communication
04

Disease associations

Cancer (especially epithelial cancers, e.g. breast, ovarian, lung)Infection (barrier against bacteria, viruses; modulate inflammation)Inflammation (chronic diseases such as Crohn’s disease; overexpression linked to inflammatory responses)Other (lung diseases, gastrointestinal disorders)
05

Safety considerations

High molecular weight and glycosylation complicate drug delivery and targetingWidespread physiological roles raise risk of off-target toxicity (e.g., damage to healthy epithelium)Potential for immunogenicity with antibody therapies
06

Interacting drugs

Immunotherapies (e.g., MUC1 and MUC16 targeted antibodies in cancer)

2 more in the full profile.

07

Biomarkers

MUC1, MUC16 (CA125), and other specific mucins used as biomarkers in cancersGlycosylation patterns (e.g., Thomsen-Friedenreich antigen, Tn, sialyl-Tn antigen in cancer)Overexpression or altered forms in disease tissues

Beyond the preview

Go deeper on Mucin and epithelial cell surface protein (May be abbreviated as "MUC" for specific family members (e.g., MUC1, MUC4, MUC16), but there is no standardized abbreviation for the broad group "mucins and epithelial cell surface proteins").

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucin and epithelial cell surface protein (May be abbreviated as "MUC" for specific family members (e.g., MUC1, MUC4, MUC16), but there is no standardized abbreviation for the broad group "mucins and epithelial cell surface proteins").

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call